Coronary thrombosis and pulmonary thromboembolism are common causes of cardiac arrest. We assessed whether the administration of tissue plasminogen activator (t-PA) during cardiopulmonary ...

A new research paper was published in Volume 17, Issue 9 of Aging-US on September 11, 2025, titled "Roles of plasminogen ...

Urokinase plasminogen activator (uPA) regulates a proteolytic cascade that facilitates cancer invasion through degradation of the extracellular matrix, and high levels of uPA in human breast cancer ...

If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...

There is now good evidence that a series of genetic alterations in both dominant oncogenes and tumour suppressor genes are involved in the pathogenesis of human colorectal cancer (CRC). Activation of ...

Proceedings of the National Academy of Sciences of the United States of America, Vol. 87, No. 3 (1990), pp. 1114-1118 (5 pages) To improve the efficacy of plasminogen activators, we produced a ...

NEW YORK — Vitrectomy using balanced saline solution without tissue plasminogen activator is effective for displacement of thick submacular hemorrhage, according to a speaker here. “As you all know, ...

TISSUE PLASMINOGEN ACTIVATOR (TPA) INJECTED INTRAVENOUSLY within 3 hours of symptom onset has emerged as a treatment option for acute ischemic stroke. Although controversial and not universally ...

A new study published online in the Journal of Trauma and Acute Care Surgery in March 2020 reports that the anticoagulation drug tPA could be a potential aid in managing respiratory failure in ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global tissue plasminogen activator market is estimated to be valued at US$ 2,455.4 million in 2020 and is expected to exhibit a ...